273 related articles for article (PubMed ID: 30735523)
1. Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
Sabarimurugan S; Kumarasamy C; Baxi S; Devi A; Jayaraj R
PLoS One; 2019; 14(2):e0209760. PubMed ID: 30735523
[TBL] [Abstract][Full Text] [Related]
2. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
Shaw P; Senthilnathan R; Krishnan S; Suresh D; Shetty S; Muthukaliannan GK; Mani RR; Sivanandy P; Chandramoorthy HCK; Gupta MM; Baxi S; Jayaraj R
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503179
[No Abstract] [Full Text] [Related]
3. Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis.
Abusalah MAH; Irekeola AA; Hanim Shueb R; Jarrar M; Yean Yean C
PLoS One; 2022; 17(4):e0266893. PubMed ID: 35436288
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Lamichhane SR; Thachil T; Gee H; Milic N
Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol.
Kumarasamy C; Devi A; Jayaraj R
Syst Rev; 2018 Oct; 7(1):150. PubMed ID: 30285880
[TBL] [Abstract][Full Text] [Related]
6. Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.
Jayaraj R; Polpaya K; Kunale M; Kodiveri Muthukaliannan G; Shetty S; Baxi S; Mani RR; Paranjothy C; Purushothaman V; Kayarohanam S; Janakiraman AK; Balaraman AK
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553594
[No Abstract] [Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
Sabarimurugan S; Madurantakam Royam M; Das A; Das S; K M G; Jayaraj R
Mol Diagn Ther; 2018 Dec; 22(6):653-669. PubMed ID: 30259393
[TBL] [Abstract][Full Text] [Related]
9. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
11. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
[TBL] [Abstract][Full Text] [Related]
12. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
[TBL] [Abstract][Full Text] [Related]
16. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
[TBL] [Abstract][Full Text] [Related]
17. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
18. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis.
Zhang M; Wei S; Su L; Lv W; Hong J
Medicine (Baltimore); 2016 Aug; 95(35):e4494. PubMed ID: 27583859
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Su L; Zhang M; Zhang W; Cai C; Hong J
Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
